Quest Return on Average Assets from 2010 to 2024

DGX Stock  USD 125.91  1.07  0.84%   
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest main balance sheet or income statement drivers, such as Depreciation And Amortization of 280.4 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many exotic indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
This module can also supplement Quest Diagnostics' financial leverage analysis and stock options assessment as well as various Quest Diagnostics Technical models . Check out the analysis of Quest Diagnostics Correlation against competitors.

About Quest Diagnostics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Quest Diagnostics income statement, its balance sheet, and the statement of cash flows. Quest Diagnostics investors use historical funamental indicators, such as Quest Diagnostics's Return on Average Assets, to determine how well the company is positioned to perform in the future. Although Quest Diagnostics investors may use each financial statement separately, they are all related. The changes in Quest Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Quest Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Quest Diagnostics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Pair Trading with Quest Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quest Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving against Quest Stock

  0.6TIL Instil Bio Financial Report 9th of May 2024 PairCorr
  0.42EWTX Edgewise Therapeutics Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Quest Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quest Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quest Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quest Diagnostics Incorporated to buy it.
The correlation of Quest Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quest Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quest Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quest Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:
Check out the analysis of Quest Diagnostics Correlation against competitors.
Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.868
Dividend Share
2.84
Earnings Share
7.49
Revenue Per Share
82.607
Quarterly Revenue Growth
(0.02)
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.